Photobiomodulation for Myofascial Pelvic Pain

Description

The goal of this clinical trial is to evaluate the efficacy of photobiomodulation of the pelvic floor muscles in female Veterans with chronic pelvic pain. The main questions it aims to answer are: * Is there a difference in reduction in overall pelvic pain between women who undergo photobiomodulation compared to women who received pelvic floor physical therapy? * Is there a difference in compliance with therapy between the two groups? Participants will be randomized to treatment with either 9 treatments of photobiomodulation (two treatments per week) or 8 weeks of pelvic floor physical therapy (one treatment a week). Researchers will compare both groups to see if there is a difference in overall pelvic pain reduction.

Conditions

Pelvic Pain, Levator Ani Syndrome, Spastic Pelvic Floor Syndrome, Chronic Pelvic Pain Syndrome, Myalgia of Pelvic Floor

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to evaluate the efficacy of photobiomodulation of the pelvic floor muscles in female Veterans with chronic pelvic pain. The main questions it aims to answer are: * Is there a difference in reduction in overall pelvic pain between women who undergo photobiomodulation compared to women who received pelvic floor physical therapy? * Is there a difference in compliance with therapy between the two groups? Participants will be randomized to treatment with either 9 treatments of photobiomodulation (two treatments per week) or 8 weeks of pelvic floor physical therapy (one treatment a week). Researchers will compare both groups to see if there is a difference in overall pelvic pain reduction.

Photobiomodulation Therapy for Myofascial Pelvic Pain: A Randomized Clinical Study

Photobiomodulation for Myofascial Pelvic Pain

Condition
Pelvic Pain
Intervention / Treatment

-

Contacts and Locations

Orlando

Orlando VA Medical Center, Orlando, Florida, United States, 32827

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinically diagnosed MFPP
  • * Age ≥ 18
  • * Able to provide informed consent
  • * English speaking
  • * Agree not to participate in any other form of treatment of myofascial pelvic pain for 3 months after end of trial
  • * Prior pelvic floor physical therapy or SoLá therapy for pelvic pain
  • * Pregnancy documented by urine or blood
  • * Taking drugs that have heat- or light- sensitive contraindications
  • * Reporting decreased sensation in the vagina or rectum or if they are found to have abnormalities on the external neurosensory exam of the vagina
  • * Have a known history of cancer of the cervix, vagina, uterus, bladder, or vulva or suspected to have neoplasia or pre-cancerous lesions
  • * Have an active infection of the bladder, vagina, vulva, or urethra
  • * Have active vaginal bleeding or blood in the vaginal canal
  • * Have evidence of active vaginal trauma, ulcerations, erosions, or other evidence of vaginal and vulvar skin breakdown
  • * Cannot tolerate vaginal examination either due to discomfort, pain or history or traumatic experience

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Orlando VA Medical Center,

Study Record Dates

2024-08-01